Related Experiment Video

Updated: May 21, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Antimicrobial, anti-TB, anticancer and anti-HIV evaluation of new s-triazine-based heterocycles

Rahul V Patel1, Premlata Kumari, Dhanji P Rajani

  • 1Department of Applied Chemistry, S.V. National Institute of Technology, Surat 395 007, India. rahul.svnit11@gmail.com

Future Medicinal Chemistry
|June 20, 2012
PubMed
Abstract

Insights

Newly synthesized s-triazine compounds show promising in vitro activity against drug-resistant microbes, cancer cell lines, and HIV strains. These findings highlight their potential for future drug discovery and development.

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Antimicrobial Research

Background:

  • Antimicrobial resistance poses a significant global public health threat.
  • Tuberculosis (TB) and various cancers, including breast and prostate cancer, are leading causes of mortality worldwide.
  • Human Immunodeficiency Virus (HIV) remains a major global health concern.

Purpose of the Study:

  • To synthesize novel s-triazine compounds.
  • To evaluate the in vitro antimicrobial, anticancer, and antiviral activities of these compounds.
  • To confirm the chemical structures of the synthesized compounds.

Main Methods:

  • Synthesis of novel s-triazine derivatives.
  • In vitro testing against a panel of microorganisms (bacteria, fungi, Mycobacteria).
  • In vitro evaluation against breast and prostate cancer cell lines.
  • In vitro assessment against HIV-1 and HIV-2 viral strains.
  • Structural elucidation using spectroscopic techniques (IR, NMR) and elemental analysis.

Main Results:

  • The newly synthesized s-triazine compounds exhibited significant in vitro activity against a diverse range of microorganisms.
  • These compounds demonstrated promising in vitro efficacy against breast and prostate cancer cell lines.
  • The s-triazines were also found to be active against HIV-1 and HIV-2 strains in vitro.
  • Structural confirmation studies were consistent with the proposed molecular structures.

Conclusions:

  • The evaluated s-triazine derivatives show considerable potential for future drug discovery efforts.
  • These compounds represent attractive candidates for the development of new therapeutic agents against infectious diseases and cancer.
  • The activity profiles warrant further investigation for preclinical and clinical development.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Concept Videos

Aryldiazonium Salts to Azo Dyes: Diazo Coupling01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
Aromatic Hydrocarbon Cations: Structural Overview01:18

Aromatic Hydrocarbon Cations: Structural Overview

Cycloheptatriene is a neutral monocyclic unsaturated hydrocarbon that consists of an odd number of carbon atoms and an intervening sp3 carbon in the ring. The three double bonds in the ring correspond to 6 π electrons, which is a Huckel number, and therefore satisfies the criteria of 4n + 2 π electrons. However, the intervening sp3 carbon disrupts the continuous overlap of p orbitals. As a result, cycloheptatriene is not aromatic.
Removing one hydrogen from the intervening CH2 group with both...
Basicity of Heterocyclic Aromatic Amines01:25

Basicity of Heterocyclic Aromatic Amines

Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
Five-Membered Heterocyclic Aromatic Compounds: Overview01:13

Five-Membered Heterocyclic Aromatic Compounds: Overview

Heterocyclic aromatic compounds are cyclic compounds that are aromatic and have one or more heteroatoms—atoms other than carbon, in the ring. Depending upon the number of atoms present in the ring, they can be either five or six-membered. Examples of five-membered heterocyclic aromatic compounds include pyrrole, furan, thiophene, and imidazole. Pyrrole consists of one nitrogen atom having one lone pair of electrons. Furan and thiophene have one oxygen and one sulfur heteroatom, respectively.
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...